Company intelligence / Profile preview
Medigen Vaccine Biologics Corporation
Neihu District, Taipei City, Taiwanmedigenvac.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Medigen’s COVID‑19 vaccine received Emergency Use Authorization in Taiwan and Paraguay; it was selected for the WHO Solidarity Trial and has undergone global Phase III trials. The company’s quadrivalent influenza vaccine and EV71 vaccine have been licensed in Taiwan as of late 2023. The dengue vaccine completed a Phase II proof-of-concept trial[7][9].
- Therapeutic areas
- Infectious Diseases
- Modalities
- Protein subunit vaccinesCell-based vaccinesBiosimilars
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →03
Partnerships
Dynavax Technologies – CpG1018 adjuvant for COVID‑19 vaccineBlueWillow Biologics – Intranasal COVID‑19 vaccine development using NanoVax adjuvant technologyU.S. NIH/Vaccine Research Center – Technology license for S‑2P spike protein used in MVC-COV1901
Beyond the preview
Go deeper on Medigen Vaccine Biologics Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Medigen Vaccine Biologics Corporation.